522 related articles for article (PubMed ID: 32358994)
1. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston SL
Allergy; 2020 Jul; 75(7):1543-1545. PubMed ID: 32358994
[No Abstract] [Full Text] [Related]
2. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
3. COVID-19, severe asthma, and biologics.
García-Moguel I; Díaz Campos R; Alonso Charterina S; Fernández Rodríguez C; Fernández Crespo J
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):357-359.e1. PubMed ID: 32553608
[No Abstract] [Full Text] [Related]
4. Impact of the COVID-19 pandemic in children with allergic asthma.
Ruano FJ; Somoza Álvarez ML; Haroun-Díaz E; Vázquez de la Torre M; López González P; Prieto-Moreno A; Torres Rojas I; Cervera García MD; Pérez Alzate D; Blanca-López N; Canto Díez G
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3172-3174.e1. PubMed ID: 32730834
[No Abstract] [Full Text] [Related]
5. Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?
Regazzoni V; Loffi M; Garini A; Danzi GB
Circ J; 2020 Sep; 84(10):1887. PubMed ID: 32779609
[No Abstract] [Full Text] [Related]
6. Is the type of diabetes treatment relevant to outcome of COVID-19?
Bloomgarden Z
J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
[No Abstract] [Full Text] [Related]
7. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
8. Reactivation of COVID-19 pneumonia: A report of two cases.
Ravioli S; Ochsner H; Lindner G
J Infect; 2020 Aug; 81(2):e72-e73. PubMed ID: 32389787
[No Abstract] [Full Text] [Related]
9. The potential role of nanomedicine on COVID-19 therapeutics.
Mainardes RM; Diedrich C
Ther Deliv; 2020 Jul; 11(7):411-414. PubMed ID: 32594863
[No Abstract] [Full Text] [Related]
10. Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.
Barroso B; Valverde-Monge M; Cañas Jose A; Rodrigo-Muñoz JM; Gonzalez-Cano B; Villalobos-Violan V; Betancor D; Gomez-Cardeñosa A; Vallejo-Chamorro G; Baptista-Serna L; Villalobos-Vilda C; Ortega-Martin L; Gómez-López A; Sanchez-Pernaute O; Romero-Bueno F; Rodriguez-Nieto MJ; Del Pozo V; Sastre J;
J Investig Allergol Clin Immunol; 2020; 30(5):382-384. PubMed ID: 32554336
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Mégarbane B; Scherrmann JM
J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
[No Abstract] [Full Text] [Related]
12. Association of asthma and its genetic predisposition with the risk of severe COVID-19.
Zhu Z; Hasegawa K; Ma B; Fujiogi M; Camargo CA; Liang L
J Allergy Clin Immunol; 2020 Aug; 146(2):327-329.e4. PubMed ID: 32522462
[No Abstract] [Full Text] [Related]
13. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
Arboleda JF; Urcuqui-Inchima S
Front Immunol; 2020; 11():1523. PubMed ID: 32655583
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour M; Al-Kofahi M; Austin D
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
[No Abstract] [Full Text] [Related]
15. Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
Roncon L; Zuin M; Zonzin P
J Thromb Thrombolysis; 2020 Jul; 50(1):221-222. PubMed ID: 32394238
[No Abstract] [Full Text] [Related]
16. Dexamethasone nanomedicines for COVID-19.
Lammers T; Sofias AM; van der Meel R; Schiffelers R; Storm G; Tacke F; Koschmieder S; Brümmendorf TH; Kiessling F; Metselaar JM
Nat Nanotechnol; 2020 Aug; 15(8):622-624. PubMed ID: 32747742
[No Abstract] [Full Text] [Related]
17. Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto.
Seung Kim JH; Georgakopoulos JR; Yeung J
J Cutan Med Surg; 2020; 24(5):534-535. PubMed ID: 33023343
[No Abstract] [Full Text] [Related]
18. Does asthma affect morbidity or severity of COVID-19?
Matsumoto K; Saito H
J Allergy Clin Immunol; 2020 Jul; 146(1):55-57. PubMed ID: 32470485
[No Abstract] [Full Text] [Related]
19. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 pandemic: challenges ahead.
Márquez-González H; Miranda-Novales MG; Solórzano-Santos F; Klunder-Klunder M; Garduño-Espinoza J; Méndez-Galván JF
Bol Med Hosp Infant Mex; 2020; 77(5):242-251. PubMed ID: 33064677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
